$ Value
$0
Shares
6,578
Price
$0
Filed
Aug 11
Insider
Name
Jones Marie L.
Title
Chief Accounting Officer, VP
CIK
0001968991
Roles
Transaction Details
Transaction Date
2025-08-11
Code
C
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
Represents restricted stock units ("RSUs"), with a vesting commencement date of August 7, 2025 (the "Vesting Commencement Date"). 1/16th of the RSUs vest on each quarterly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date. | Upon the closing of Heartflow, Inc.'s ("Heartflow") initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of Heartflow's common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II above on an as-converted basis. | 1/4th of the options will vest on January 8, 2026, and the remaining shares will vest and become exercisable in monthly installments until January 8, 2029, subject to continued service through the applicable vesting date. | The option vests 1/48 on each monthly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date.
Filing Info
Jones Marie L.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-06 | HTFL | F | $3K |
| 2026-02-06 | HTFL | A | $0 |
| 2026-02-06 | HTFL | A | $0 |
| 2025-11-07 | HTFL | F | $3K |
| 2025-08-11 | HTFL | C | — |
| 2025-08-11 | HTFL | C | $0 |
| 2025-08-07 | HTFL | A | $0 |
| 2025-08-07 | HTFL | A | $0 |
| 2025-03-13 | HTFL | A | $0 |
Other Insiders at HTFL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| BARABE TIMOTHY C | — | — | 2026-03-11 |
| HealthCor Partners Management LP | — | — | 2026-03-24 |
| Lightcap Jeffrey C | — | — | 2026-03-24 |
|
Rogers Campbell
Chief Medical Officer
|
— | $4.8M | 2026-04-01 |
| Bain Capital Life Sciences Investors, LLC | — | $56.1M | 2026-02-04 |
| Cullivan Julie A | — | $447K | 2026-03-05 |
|
Farquhar John C.M.
Chief Executive Officer
|
— | $1.8M | 2026-04-10 |
|
Jones Marie L.
Chief Accounting Officer, VP
|
— | — | 2026-02-06 |
|
Verghese Vikram
Chief Financial Officer
|
— | — | 2026-02-06 |